136 related articles for article (PubMed ID: 28219857)
1. [Coexpression of MAP2K4 and vimentin proteins in human endometrial carcinoma and its clinicopathological significance].
Liu CH; Jiang QP; Lin D; Chen W; Xiao YY; Lin L; Deng YR; Jiang HP; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):157-164. PubMed ID: 28219857
[TBL] [Abstract][Full Text] [Related]
2. Value of serum p53, PKD1, and MAP2K4 in evaluating the condition and prognosis of endometrial carcinoma.
Zhang X; Huang Y; Pang X
Am J Transl Res; 2022; 14(7):5059-5067. PubMed ID: 35958483
[TBL] [Abstract][Full Text] [Related]
3. Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.
Cai S; Zhang YX; Han K; Ding YQ
Arch Gynecol Obstet; 2017 Jul; 296(1):93-98. PubMed ID: 28474124
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of MAP2K4 and estrogen receptor and their clinical significance in invasive breast cancer].
Liu S; Liu YY; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):488-493. PubMed ID: 28446401
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of DAPK3 and c-Myc in endometrial cancer and their relationship with the patients' prognosis].
Chen C; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):863-9. PubMed ID: 27320893
[TBL] [Abstract][Full Text] [Related]
6. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
Yu CG; Jiang XY; Li B; Gan L; Huang JF
Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of MIIP and PAK1 in endometrial carcinoma].
Jiang S; Tian WY; Yan Y; Teng F; Gao JP; Wang YM; Xue FX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):359-364. PubMed ID: 29860763
[No Abstract] [Full Text] [Related]
8. Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma.
Coppola D; Fu L; Nicosia SV; Kounelis S; Jones M
Hum Pathol; 1998 May; 29(5):455-62. PubMed ID: 9596268
[TBL] [Abstract][Full Text] [Related]
9. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract][Full Text] [Related]
10. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma.
Erkanli S; Bolat F; Kayaselcuk F; Demirhan B; Kuscu E
Gynecol Oncol; 2007 Feb; 104(2):320-5. PubMed ID: 17030351
[TBL] [Abstract][Full Text] [Related]
11. Expression of PTEN and β-Catenin and Their Relationship With Clinicopathological and Prognostic Factors in Endometrioid Type Endometrial Cancer.
Sal V; Demirkiran F; Erenel H; Tokgozoglu N; Kahramanoglu I; Bese T; Turan H; Sofiyeva N; Calay Z; Arvas M; Guralp O
Int J Gynecol Cancer; 2016 Mar; 26(3):512-20. PubMed ID: 26894937
[TBL] [Abstract][Full Text] [Related]
12. [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].
Lin L; Jiang QP; Lin D; Chen W; Jiang HP; Liu CH; Xiao YY; Zhu LT; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):471-476. PubMed ID: 29735450
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
14. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
15. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
16. [High expression of MMP20 may be a potential prognostic factor for poor outcomes of patients with endometrial carcinoma].
Zhao Q; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1239-1244. PubMed ID: 30377136
[TBL] [Abstract][Full Text] [Related]
17. Visfatin, a potential biomarker and prognostic factor for endometrial cancer.
Tian W; Zhu Y; Wang Y; Teng F; Zhang H; Liu G; Ma X; Sun D; Rohan T; Xue F
Gynecol Oncol; 2013 Jun; 129(3):505-12. PubMed ID: 23438672
[TBL] [Abstract][Full Text] [Related]
18. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
20. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
